fashion -WSS

fashion

author：Wikipedia 2025-09-27 12:57:15 - browse：3819

TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson & Johnson, Novartis, and Novo Nordisk deployed a half-dozen lawyers to a courtroom here Thursday in a bid to dismantle Medicare’s new drug price negotiation program, just hours before President Biden is set to glorify it in his State of the Union.

A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drugmakers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.

Over four hours, the debate spanned most of the substantive issues that pharmaceutical companies and their allies have raised across the country, both in constitutional challenges to the law and in challenges to how Medicare officials have interpreted the law so far. That means the court’s decision in these cases could produce a first substantive test for several of the arguments that haven’t been addressed by courts in other states, where companies like Boehringer Ingelheim, AstraZeneca, and Merck are also suing, separately, over the same law.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Why did Pfizer dish out millions for a Super Bowl ad?

WSS

FDA advisers vote against ALS treatment from BrainStorm

WHO recommends dropping component of many flu vaccines

WHO recommends dropping component of many flu vaccines

BioAge raises $170M for combination therapy with Zepbound

Key House Republican on health care plans exit from Congress

Kaiser Permanente unions announce official strike date

focus

fashion

hotspot

Bright Health sells Medicare Advantage business to Molina

Covid vaccines: Private market messier than government rollout

Medicare proposal to cover medical devices draws a mixed reaction

Did you have Obamacare on your GOP debate bingo card?

Hepatitis C has a cure — but many Americans still lack access to it

BioAge raises $170M for combination therapy with Zepbound

Peter Hotez and the public health issue of online harassment

Paxlovid should be available without a positive Covid test

Malaria cases in Florida and Texas: Here’s what you need to know

Biogen shutters digital health group, ends Apple study, in cost cutting move

explore

Kaiser Permanente unions announce official strike date

Biden report: The neurospychology of memory and aging

Listen: Who gets the credit for GLP

Biogen shutters digital health group, ends Apple study, in cost cutting move

KalVista pill reduced swelling 'attacks' caused by genetic disease

Doctors' information doesn't help them choose wisely when sick

focus

knowledge

hotspot

leisure time